1. Home
  2. SLQT vs PCRX Comparison

SLQT vs PCRX Comparison

Compare SLQT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SelectQuote Inc.

SLQT

SelectQuote Inc.

HOLD

Current Price

$0.68

Market Cap

151.6M

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.21

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLQT
PCRX
Founded
1999
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.6M
1.0B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
SLQT
PCRX
Price
$0.68
$23.21
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$2.88
$37.60
AVG Volume (30 Days)
1.3M
754.0K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
105.00
107.44
EPS
0.01
0.16
Revenue
$1,526,594,000.00
$541,533,000.00
Revenue This Year
$11.42
$9.77
Revenue Next Year
$7.76
$9.71
P/E Ratio
$65.02
$145.38
Revenue Growth
15.50
26.04
52 Week Low
$0.65
$18.80
52 Week High
$3.97
$27.99

Technical Indicators

Market Signals
Indicator
SLQT
PCRX
Relative Strength Index (RSI) 28.80 52.99
Support Level N/A $20.09
Resistance Level $0.94 $24.65
Average True Range (ATR) 0.06 1.11
MACD 0.00 0.06
Stochastic Oscillator 11.68 66.38

Price Performance

Historical Comparison
SLQT
PCRX

About SLQT SelectQuote Inc.

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: